Peter Feinberg
Director/Board Member en IMMUNEERING CORPORATION .
Fortuna: 3 M $ al 31/03/2024
Perfil
Peter Feinberg is the founder of BridgeBio Pharma, Inc. (2014) and Boxcar PMJ LLC (2019).
Mr. Feinberg is also the founder of North Coast Partners LLP, Sporos Bioventures, Inc...
Mr. Feinberg's current jobs include Director at Immuneering Corp.
(since 2021), Independent Director at Notable Labs Ltd.
(since 2023), and Partner at Boxcar Partners (since 2019).
Mr. Feinberg's former job was as MD & Head-Institutional Equities Trading at Oppenheimer & Co., Inc. (2015).
Mr. Feinberg's education history includes undergraduate studies at Whittier College.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 22/03/2024 | 1 096 064 ( 3.74% ) | 3 M $ | 31/03/2024 |
Cargos activos de Peter Feinberg
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUNEERING CORPORATION | Director/Board Member | 01/01/2021 |
Boxcar PMJ LLC
 Boxcar PMJ LLC Boxcar PMJ LLC is an Independent Venture Capital firm founded in 2019 by Peter Feinberg. The firm is headquartered in the US. | Founder | 01/06/2019 |
Sporos Bioventures, Inc.
 Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Founder | - |
| Boxcar Partners | Corporate Officer/Principal | 01/06/2019 |
Antiguos cargos conocidos de Peter Feinberg.
| Empresas | Cargo | Fin |
|---|---|---|
Oppenheimer & Co., Inc.
 Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Corporate Officer/Principal | 31/01/2015 |
| North Coast Partners LLP | Founder | - |
| BRIDGEBIO PHARMA, INC. | Founder | - |
Formación de Peter Feinberg.
| Whittier College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 2 |
|---|---|
| IMMUNEERING CORPORATION | Health Technology |
| BRIDGEBIO PHARMA, INC. | Health Technology |
| Empresas privadas | 5 |
|---|---|
Oppenheimer & Co., Inc.
Oppenheimer & Co., Inc. Investment ManagersFinance Oppenheimer & Co., Inc. provides security brokerage services. It also offers investment banking and advice to high net worth investors, individuals, businesses and institutions. The company is headquartered in New York, NY. | Finance |
Boxcar PMJ LLC
Boxcar PMJ LLC Boxcar PMJ LLC is an Independent Venture Capital firm founded in 2019 by Peter Feinberg. The firm is headquartered in the US. | |
Sporos Bioventures, Inc.
Sporos Bioventures, Inc. Medical/Nursing ServicesHealth Services Sporos Bioventures, Inc. is a private biopharmaceutical company based in Houston, TX. Sporos Bioventures, Inc. aims to transform the drug development process by identifying novel disease mechanisms and strategically deploying talent, capital, and access to operational resources to catalyze the development of breakthrough medicines. Sporos' current pipeline is diversified across three business units and includes multiple clinical-stage candidates that are being investigated for the treatment of multiple indications in cancer and immune disease. The company provides centralized expertise, resources, and core infrastructure so that the portfolio companies can focus primarily on their research development programs. The company was founded by Peter Feinberg, Ronald A. DePinho, Jeno Gyuris, Joseph Kekst, Harold Levy, Alex M. Cranberg, Louis Feinberg, Michael S. Wyzga, Dana Levy, and the CEO is Stephen Rubino. | Health Services |
| Boxcar Partners | |
| North Coast Partners LLP |
- Bolsa de valores
- Insiders
- Peter Feinberg
